MindMate: A Study of a Reminder System for People With Dementia
NCT02908997 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3
Last updated 2018-11-06
Summary
A study to investigate the effectiveness of a reminder tool application at increasing performance on memory tasks in people with mild dementia
Conditions
Interventions
- OTHER
-
MindMate
A dementia-specific mobile reminding application
Sponsors & Collaborators
-
University of Glasgow
collaborator OTHER -
NHS Greater Glasgow and Clyde
lead OTHER
Principal Investigators
-
Jonathan Evans, BSc DClinPsy PhD · University of Glasgow
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-01-17
- Primary Completion
- 2018-07-31
- Completion
- 2018-07-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Comparison of Once Daily and Twice Daily Dosing on Safety and Tolerability of Memantine in Patients With Alzheimer
NCT02553928 ·Status: COMPLETED ·Phase: PHASE4
-
Memory and Mental Health in Aging
NCT02988908 ·Status: COMPLETED ·Phase: PHASE4
-
Prediction of Cognitive Properties of Memantine for Neurodegenerative Diseases
NCT02288000 ·Status: TERMINATED ·Phase: PHASE1
-
Memantine and Comprehensive, Individualized Management of Alzheimer's Disease and Caregiver Training
NCT00120874 ·Status: COMPLETED ·Phase: PHASE4
-
Memantine and Comprehensive, Individualized, Patient Centered Management of Alzheimer's Disease: Health Outcome
NCT02854917 ·Status: COMPLETED
-
Minocycline in Patients With Alzheimer's Disease
NCT01463384 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Tolerability of Memantine in Frontotemporal Dementia (FTD) Patients
NCT00200538 ·Status: COMPLETED ·Phase: PHASE2
-
Memantine Treatment in Alzheimer's Disease Patients
NCT03168997 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study of CST-2032 and CST-107 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's or Alzheimer's Disease
NCT05104463 ·Status: COMPLETED ·Phase: PHASE2
-
The Use of Memantine for Prevention of Alzheimer's Disease
NCT05063851 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Assess the Prognostic Usefulness of Flutemetamol (18F) Injection for Identifying Subjects With Amnestic Mild Cognitive Impairment Who Will Convert to Clinically Probable Alzheimer's Disease
NCT01028053 ·Status: COMPLETED ·Phase: PHASE3
-
Biomarker Predictors of Memantine Sensitivity in Patients With Alzheimer's Disease
NCT03703856 ·Status: COMPLETED ·Phase: PHASE4
-
Magnetic Resonance Spectroscopy Study of Memantine in Alzheimer's Disease
NCT00551161 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Memantine in Moderate to Severe Alzheimer's Disease
NCT00857649 ·Status: TERMINATED ·Phase: PHASE3
-
The Efficacy of a Combination Regimen in Patients With Mild to Moderate Probable Alzheimer's Disease
NCT01921972 ·Status: COMPLETED ·Phase: PHASE4
-
Screening for Memory Studies
NCT01123018 ·Status: ACTIVE_NOT_RECRUITING
-
A Study of Crenezumab in Participants With Mild to Moderate Alzheimer Disease
NCT02353598 ·Status: COMPLETED ·Phase: PHASE1
-
Memantine (10mg BID) for the Frontal and Temporal Subtypes of Frontotemporal Dementia
NCT00545974 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Mirtazapine for Agitation in Dementia
NCT03031184 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of Semorinemab in Patients With Prodromal to Mild Alzheimer's Disease
NCT03289143 ·Status: TERMINATED ·Phase: PHASE2
-
Effects of Memantine on Magnetic Resonance (MR) Spectroscopy in Subjects at Risk for Alzheimer's Disease
NCT00933608 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Memantine in Assessment of Selected Measures of Volumetric Magnetic Resonance Imaging (MRI) and Cognition in Moderate AD (Alzheimer's Disease)
NCT00334906 ·Status: COMPLETED ·Phase: PHASE4
-
Screening and Evaluation of Patients With Signs and Symptoms of Alzheimer's Disease
NCT00955422 ·Status: COMPLETED
-
Safety and Efficacy of MEM 1003 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease
NCT00257673 ·Status: COMPLETED ·Phase: PHASE2
-
Brain Uptake and Safety With Probable Alzheimer's Disease, Amnestic Mild Cognitive Impairment and Healthy Volunteers
NCT00785759 ·Status: COMPLETED ·Phase: PHASE2